指南与共识临床试验与 GCP医学教育与科研方法

标准化胃癌手术试验结局报告:核心结局集及配套结局测量工具集开发方案(GASTROS研究)

Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study).
指南 / 共识 · Trials · 2017-08-09

该方案计划通过三阶段国际共识研究制定胃癌手术试验的核心结局集(COS)及测量工具集。第一阶段从系统综述和患者访谈中提取潜在重要结局长清单;第二阶段采用eDelphi调查对患者、专科护士和外科医生进行优先级排序,并由利益相关者代表会议批准COS;第三阶段通过测量工具质量评估和利益相关者咨询确定合适测量工具。研究旨在标准化未来胃癌治疗性手术干预试验的结局报告,以增强临床实践证据基础并确保患者视角居于核心。

要点

  • GASTROS研究采用三阶段国际共识方法制定胃癌手术试验核心结局集(COS)。
  • 第一阶段通过系统综述和患者访谈提取潜在重要结局长清单。
  • 第二阶段eDelphi调查纳入患者、专科护士和外科医生对结局进行优先级排序。

核心结论

  • 该研究旨在通过国际共识过程标准化未来胃癌治疗性手术干预试验的结局报告。
  • 预期结局报告标准化将增强手术有效性试验的临床实践证据基础。
  • 突出对患者最重要的结局将确保患者视角居于该领域研究的核心。

研究设计与样本

  • 研究为三阶段国际共识研究方案,对象为胃癌治疗性手术干预试验的结局报告。
  • 第一阶段从相关学术文献系统综述和患者访谈中提取潜在重要结局长清单。
  • 第二阶段采用eDelphi调查,考虑患者、专科护士和外科医生的意见以优先排序最重要结局。
  • 利益相关者代表会议将批准核心结局集(COS)。
  • 第三阶段通过现有测量工具的质量评估和利益相关者咨询确定测量优先结局的合适工具。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer is one of the leading causes of cancer-related deaths worldwide. Whilst surgery is the mainstay of curative treatment, it is associated with significant risks. Surgical strategies for treating gastric cancer should be based on evidence from systematic reviews of well-designed randomised controlled trials. However, inconsistencies in the reporting of outcomes from these trials makes evidence synthesis unreliable. We present a protocol for an international consensus study to develop a standardised set of outcomes and measurement tools - a 'core outcome set' (COS) - to be used by all future trials examining therapeutic surgical interventions for gastric cancer. The GASTROS study aims to standardise the reporting of outcomes in gastric cancer surgery trials through an international consensus process of key stakeholders including health care professionals and patients. METHODS: The first of three stages in the study will identify a 'long-list' of potentially important outcomes to be prioritised. These will be extracted from a systematic review of relevant academic literature and patient interviews. Stage 2 will comprise an eDelphi survey which will consider the views of patients, nurse specialists and surgeons to prioritise the most important outcomes. A meeting of stakeholder representatives will ratify the COS. Stage 3 will focus on identifying appropriate instruments to measure the prioritised outcomes by means of quality assessment of available measurement instruments and stakeholder consultation. DISCUSSION: This study aims to standardise the reporting of outcomes in future trials examining therapeutic surgical interventions for gastric cancer. It is anticipated that standardisation of outcome reporting in these surgical effectiveness trials will enhance the evidence base for clinical practice. Highlighting outcomes of greatest importance to patients will ensure that their perspectives are central to research in this field.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Alkhaffaf B, Glenny AM, Blazeby JM, et al. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study). Trials. 2017. PMID: 28793921. doi:10.1186/s13063-017-2100-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。